722 results on '"Lumen, Nicolaas"'
Search Results
2. Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice
3. MP78-14 INTERNATIONAL EXPERT CONSENSUS ON DEVELOPMENT OF A STATE OF THE ART MALE GENITAL SIMULATION MODEL FOR URETHROPLASTY AND ARTIFICIAL URINARY SPHINCTER INSERTION
4. Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
5. Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging: 18F-PSMA-11 PET/CT and Impact on Prostate CancerManagement
6. Experiences of Men With Prostate Cancer Participating in a Clinical Pathway With a Supervised Group-based Exercise Program to Combat Androgen Deprivation-Induced Side Effects: A Qualitative Focus Group Study
7. Is a Course of Intermittent Self-dilatation with Topical Corticosteroids Superior at Stabilising Urethral Stricture Disease in Men and Improving Functional Outcomes over a Course of Intermittent Self-dilatation Alone? A Systematic Review and Meta-analysis
8. Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER Trial
9. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries
10. The Association between Urine N-Glycome and Prognosis after Initial Therapy for Primary Prostate Cancer
11. POIROT trial: post-operative imaging after urethroplasty with peri-catheter retrograde urethrography or trial of voiding with voiding cysto-urethrography
12. 18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial
13. European Association of Urology Guidelines on Urethral Stricture Disease Part 3: Management of Strictures in Females and Transgender Patients
14. What is the role of single-stage oral mucosa graft urethroplasty in the surgical management of lichen sclerosus-related stricture disease in men? A systematic review
15. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
16. Surgical Outcomes After Treatment of Urethral Complications Following Metoidioplasty in Transgender Men
17. Surgical repair of urethral complications after metoidioplasty for genital gender affirming surgery
18. Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review
19. Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients
20. Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping
21. Impact of Urethral Reconstruction on Sexual Function
22. Role of Non-transecting Anastomotic Urethroplasty for Bulbar Urethral Strictures
23. The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
24. Urethral Complications After Metoidioplasty for Genital Gender Affirming Surgery
25. A multi-institutional critical assessment of dorsal onlay urethroplasty for post-radiation urethral stenosis
26. Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry
27. Phalloplasty in cis-men with penile insufficiency: evaluation of outcomes and surgical complications: Good ability to achieve orgasm, high urinary complication rate
28. Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial
29. Current Management of Urinary Tract Injuries
30. Implantation of the ZSI 475 FTM Erectile Device After Phalloplasty: A Prospective Analysis of Surgical Outcomes
31. Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer
32. The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer
33. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study
34. Independent risk factors for failure after anterior urethroplasty: a multivariate analysis on prospective data
35. Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
36. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time
37. Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
38. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates
39. Is Nonoperative Management the Best First-line Option for High-grade Renal trauma? A Systematic Review
40. Current Management of pT3b Prostate Cancer After Robot-assisted Laparoscopic Prostatectomy
41. A unified strategy to focal brachytherapy incorporating transperineal biopsy, image fusion, and real-time implantation with and without rectal spacer simulated in prostate phantoms.
42. Suppl Data 2 from Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
43. Data from Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
44. Suppl. Data 1 from Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
45. Supplementary Figures, Tables, Notes from Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
46. Impact of Urethral Reconstruction on Sexual Function
47. Role of Non-transecting Anastomotic Urethroplasty for Bulbar Urethral Strictures
48. Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial
49. Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction
50. 4 Weeks Versus 5 Weeks of Hypofractionated High-dose Radiation Therapy as Primary Therapy for Prostate Cancer: Interim Safety Analysis of a Randomized Phase 3 Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.